Overcome the Multiple Challenges of Neutralizing Antibodies in Cancer Therapy Using Phage Display

#102: Discovery of Potent, Functional Antibodies Using Hybridoma & Phage Display Platforms WebinarПодробнее

Current Landscape and Future Directions of Multi-specific AntibodiesПодробнее

Structural Immunology (3 of 6): Anti-Cancer and Anti-COVID Antibodies Made by Phage DisplayПодробнее

Antibody-Based Therapies: Taking a BiTE Out of CancerПодробнее

Structural Immunology (3a of 6): Anti-Cancer and Anti-COVID Antibodies Made by Phage DisplayПодробнее

Antibody discovery at the edge of impossibleПодробнее

Overcome the Challenges of PK Assay Development Using TrailBlazer AntibodiesПодробнее

How to Overcome Assay Challenges Using Custom Recombinant AntibodiesПодробнее

Generation of Recombinant Tool Antibodies to Support Cell and Gene Therapy DevelopmentПодробнее

10/17/2018 Bispecific Single-Domain Antibody fused to Monoclonal Antibody (SMAB): The Natural FormПодробнее

How to overcome the navigating challenges in Immunotherapy developmentПодробнее

High Quality Therapeutic Antibodies | High-Throughput Antibody Screening | HT-SPR | LSA PlatformПодробнее

Challenges in antibody therapy for pediatric cancerПодробнее

Antibody Discovery Platforms to Support Functional Monoclonal Antibody GenerationПодробнее

Accelerate GPCR Antibody Discovery with Synthetic DNA Technologies | Melina MathurПодробнее

Structural Immunology (3b of 6): Anti-Cancer and Anti-COVID Antibodies Made by Phage DisplayПодробнее

Deep mining of early antibody response in COVID-19 patients yields potent neutralisersПодробнее

Structural Immunology 2023 4 of 7: Anti-Cancer Antibodies from the “Antibot”Подробнее

Neutralization Antibodies Onset in Phage TherapyПодробнее